Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease.

about

Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation.

P2860

Q52604682-8A592055-4D77-417E-8A8F-6525BAA0BD67

P2860

Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease.

Item

http://www.wikidata.org/entity/Q48015053

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Dabrafenib in patients with re ...... ma and leptomeningeal disease.

@en

Dabrafenib in patients with re ...... ma and leptomeningeal disease.

@nl

type

Item

label

Dabrafenib in patients with re ...... ma and leptomeningeal disease.

@en

Dabrafenib in patients with re ...... ma and leptomeningeal disease.

@nl

prefLabel

Dabrafenib in patients with re ...... ma and leptomeningeal disease.

@en

Dabrafenib in patients with re ...... ma and leptomeningeal disease.

@nl

P1476

Dabrafenib in patients with re ...... oma and leptomeningeal disease

@en

P2093

David Capper

http://www.w3.org/2001/XMLSchema#string

Joachim P Steinbach

http://www.w3.org/2001/XMLSchema#string

Marlies Wagner

http://www.w3.org/2001/XMLSchema#string

Martin Voss

http://www.w3.org/2001/XMLSchema#string

Michael C Burger

http://www.w3.org/2001/XMLSchema#string

Michael W Ronellenfitsch

http://www.w3.org/2001/XMLSchema#string

Nadja I Lorenz

http://www.w3.org/2001/XMLSchema#string

Oliver Bähr

http://www.w3.org/2001/XMLSchema#string

Theophilos Tzaridis

http://www.w3.org/2001/XMLSchema#string

Ulrich Herrlinger

http://www.w3.org/2001/XMLSchema#string

P2860

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

Mutations of the BRAF gene in human cancer

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One With BRAF(V600E) Mutation and Clinical Response to the BRAF Inhibitor Dabrafenib

Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma

BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications.

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

P304

3291-3296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OR.2017.6013

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29039591

http://www.w3.org/2001/XMLSchema#string

P932

5783574

http://www.w3.org/2001/XMLSchema#string

Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease.

about

P2860

P2860

Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932